A recent federal court decision in Texas has overturned a significant Biden administration rule that aimed to remove medical debt from credit reports, a move that directly impacts nearly 15 million Americans. The ruling, issued on July 11, 2025, by U.S. District Judge Sean Jordan, a Trump appointee, asserts that the Consumer Financial Protection Bureau (CFPB) exceeded its authority in implementing the policy.
The rule, which was finalized by the CFPB in January before President Joe Biden left office, sought to prevent approximately $50 billion in medical debt from appearing on credit reports nationwide. Its primary goal was not to discharge the debt itself, but to change how credit reporting agencies factored medical debt into credit score calculations. The Biden administration had projected that this change would boost Americans’ credit scores by an average of 20 points and could lead to an additional 22,000 approved mortgages annually, as medical debt would no longer weigh down credit decisions (Scripps News, The Economic Times).
Judge Jordan’s decision hinges on his interpretation of the Fair Credit Reporting Act (FCRA), which was last amended in 2003. He ruled that the FCRA does not grant the CFPB the power to mandate the removal of specific types of debt, such as medical debt, from credit reports. While the judge acknowledged that the CFPB can “encourage” creditors to consider other forms of consumer information when assessing creditworthiness, this approach relies on voluntary compliance rather than enforceable regulatory requirements (Rolling Out).
For the 15 million Americans who stood to benefit from improved credit scores, this reversal means that medical debt could continue to impact their financial standing. This includes potential higher borrowing costs and limited access to loans for mortgages, car purchases, or other credit-dependent transactions. Consumer advocates argue that medical debt often stems from unexpected illnesses or emergencies and is not a reliable indicator of an individual’s ability to repay other debts, making its inclusion on credit reports unfairly punitive (Times Now).
The ruling also carries broader political implications. It aligns with the Trump administration’s ongoing efforts to review and roll back regulations implemented by the Biden administration. Medical debt was a prominent issue in the 2024 presidential election, with former Vice President Kamala Harris advocating for full medical debt erasure and emphasizing that “No one should be denied economic opportunity because they got sick or experienced a medical emergency” (The Economic Times).
Industry reactions to the decision have been mixed. Dan Smith, who leads the Consumer Data Industry Association, expressed support for the judge’s ruling, stating it “protects the integrity of the system” (The Economic Times). However, consumer advocacy groups are likely to intensify pressure on Congress to pass explicit legislation that would mandate the removal of medical debt from credit reports, though such a legislative effort would require bipartisan consensus in a divided political landscape.
The path forward for affected Americans remains uncertain. While the CFPB might explore new rulemaking within its statutory limits, such actions could face significant legal challenges. The decision underscores the ongoing debate over the scope of federal agencies’ regulatory powers and the financial burdens unexpected healthcare costs place on millions of families across the United States.
